Fungus DBHCYZ-G2-1 and application of extract of fungus DBHCYZ-G2-1 in preparation of antibacterial, antioxidant or antitumor drugs
Through the liquid fermentation extract of Fusarium nirenbergiae DBHCYZ-G2-1 isolated from African spiral flag plants, the problem of insufficient targeting and safety of antibacterial drugs in the prior art was solved, and the Staphylococcus aureus was realized Effective inhibition of bacteria and food preservation effects.
Patent Information
- Application Number
- CN202411171599.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-26
AI Technical Summary
It is difficult to develop antibacterial drugs with stronger targeting and therapeutic activity in the prior art, and chemical preservatives have safety risks in the food field, which makes it of great significance to find natural, non-toxic and safe antibacterial agents.
Fusarium nirenbergiae DBHCYZ-G2-1 was isolated and identified from African spiral flag plants. Its liquid fermented extract has significant antibacterial and antioxidant activity and is used to prepare natural preservatives as antibacterial, antitumor drugs or anti-antibody agents or anti- Application of oxidation preparations.
This fungal extract has a significant inhibitory and bactericidal effect on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and E. coli, and has no obvious cytotoxicity, providing a scientific basis for natural preservatives and antioxidant drugs.
Smart Images

Figure CN119033831A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of endophytic fungi of medicinal plants, and particularly relates to application of the fungus Fusarium nirenbergiae DBHCYZ-G2-1 and an extract thereof in preparing antibacterial, antioxidant or antitumor drugs. Background Art
[0002] Endophytic fungi refer to a type of fungi that parasitize various tissues, organs and intercellular spaces of healthy plants at certain stages or all stages. They are the most promising resource for discovering small molecules of natural drugs with new structures and potent activity, and have a history of more than 100 years. Since Strobel et al. isolated Taxomyces andreanae, which can produce paclitaxel, from Taxus brevifolia, people have gradually used endophytic fungi as medicinal fungal resources to solve the drug source crisis. So far, scientists have isolated and discovered 171 genera of endophytic fungi from various medicinal plants, with as many as 1 million species. Endophytic fungi in plants have the characteristics of many species, large-scale fermentation, short culture cycle and close ecological relationship with other organisms. Secondary metabolites often show rich and diverse biological activities, including anti-tumor, anti-inflammatory, antibacterial, antioxidant, immunomodulatory, hypoglycemic and liver protection.
[0003] In recent years, searching for endophytic fungi that can produce bioactive substances from medicinal plants has become a new research hotspot in microbiology and natural drug chemistry. However, although people have done a lot of work on the types, ecological distribution, metabolites, etc. of endophytic fungi in plants, there is still a lack of comprehensive and systematic research on them. On the one hand, with the increasing number of super-resistant bacteria caused by the abuse of traditional antibiotics, it is urgent to obtain antibacterial lead drug molecules with stronger targeting and therapeutic activity; on the other hand, with the increasing improvement of people's living standards, healthy and nutritious fruit juice drinks are favored by consumers. Juice is rich in nutrients and is easily contaminated by microorganisms and causes qualitative changes. Corrupted juice not only causes waste of resources, but also easily causes poisoning, damages health, and affects consumption. Therefore, antiseptic and antibacterial inhibition has always been the top issue for juice preservation and transportation. At present, it is generally preserved by freezing, refrigeration, and chemical preservatives. The frequent safety alerts of chemical preservatives indicate that finding natural, non-toxic and safe preservatives and antimicrobial agents is also of great significance in the food field. Therefore, using endophytic fungi from medicinal plants as a treasure trove of resources for screening natural bioactive drug molecules has important research value for the development of new natural antibacterial drugs and food preservatives.
[0004] African spiral flag (Costus lucanusianus J.Braun et K,Schum), also known as African colored flag closed sheath ginger, is a plant of the genus Costus in the family Costaceae. It is native to tropical Africa and was introduced by the South China Botanical Garden of the Chinese Academy of Sciences for garden ornamental purposes. The seedlings of African spiral flag are edible, and its leaves, flowers, fruits, stems and roots can be used as traditional medicinal materials to treat fever, measles, mumps, diabetes, rheumatism, ulcers, etc., but there is a lack of sufficient scientific evidence. According to literature reports, the water extract of African spiral flag leaves has certain antioxidant activity, and its chemical composition research has found two new steroid compounds, among which the compound 3,27-dihydroxy-1-methoxy-22-cholest-5-enone shows strong antibacterial activity against S.aureus, E.coli and B.subtilis.
[0005] At present, there are no relevant research reports on the endophytic fungi of African spiral flag. Summary of the invention
[0006] The purpose of the present invention is to provide a method for preparing an endophytic fungus extract with antibacterial and preservative effects on fruit juice, and to screen the biological activities such as antibacterial, cytotoxic and antioxidant based on the extracted endophytic fungus crude extract, as well as its application and development as a coconut juice preservative and antibacterial agent.
[0007] Our research group has previously conducted research on endophytic fungi in African spiral flag plants. Through the isolation, purification and identification of endophytic fungi in plants, we obtained a Fusarium fungus Fusarium nirenbergiae DBHCYZ-G2-1. Literature research did not find any reports on the activity of secondary metabolites and extracts of this strain. Therefore, we first screened the biological activity of the liquid fermentation extract of this strain. It was found that the liquid fermentation extract of DBHCYZ-G2-1 had significant antibacterial and antioxidant activities, and no obvious cytotoxicity. It is suggested that the Fusarium nirenbergiae DBHCYZ-G2-1 strain has important theoretical guiding significance in the research and development of new non-toxic antibacterial and antioxidant drugs, as well as enriching the endophytic fungi library of ginger plants. At the same time, the extract of this strain showed a particularly significant bactericidal effect on sterile coconut milk infected with S. aureus, and can be used to prepare natural preservatives, providing a scientific basis for the development and utilization of natural new food preservatives derived from plant endophytic fungi.
[0008] Therefore, the first object of the present invention is to provide a use of Fusarium nirenbergiae DBHCYZ-G2-1, its fermentation broth, its mycelium or an organic solvent extract of its fermentation broth and mycelium in the preparation of antibacterial, antitumor drugs or antioxidant preparations.
[0009] Preferably, the antibacterial drug is a drug against Gram-positive bacteria such as Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus and Escherichia coli.
[0010] Preferably, the anti-tumor agent is anti-lung cancer or anti-cervical cancer.
[0011] Preferably, the antioxidant preparation is an antioxidant drug or an antioxidant cosmetic.
[0012] Preferably, the antibacterial agent is an antiseptic. More preferably, the antiseptic agent is an antiseptic agent for coconut water. That is, the antiseptic agent has a rapid bactericidal effect on S. aureus infected coconut water.
[0013] Preferably, the fermentation broth and mycelium are obtained by inoculating Fusarium nirenbergiae DBHCYZ-G2-1 into a culture medium in which the strain can grow, and the fermentation broth and mycelium are obtained by separation. The culture medium is further preferably PDB culture medium, and the preparation method of the PDB culture medium per liter is: boil 200g of potatoes with 300mL of pure water, boil for 20min, filter to obtain potato juice, add 20g of glucose, 3g of KH2PO4, 1.5g of MgSO4, 10mg of vitamin B1, add water to make up to 1000mL, and sterilize to obtain the obtained product.
[0014] Preferably, the culture in the culture medium is carried out at 28° C. and 120 r / min, and more preferably, the culture is carried out for 7 days.
[0015] Preferably, the organic solvent is ethyl acetate.
[0016] Preferably, the organic solvent extract is prepared by adding the fermentation liquid into ethyl acetate, mixing and pouring the mixture into a separatory funnel for extraction, standing until obvious stratification, opening the piston of the separatory funnel, collecting the ethyl acetate layer of the fermentation liquid, and obtaining a bacterial liquid extract; at the same time, ultrasonic extraction of mycelium with ethyl acetate is performed, and a mycelium extract is obtained by filtering, the bacterial liquid extract and the mycelium extract are combined, and vacuum reduced pressure concentration is performed to obtain an ethyl acetate extract.
[0017] Preferably, the extraction temperature is 25-30°C.
[0018] Preferably, the extraction is performed 3 to 5 times.
[0019] Preferably, the vacuum concentration is carried out at a temperature of 50-60°C.
[0020] The second object of the present invention is an antibacterial, antitumor drug or antioxidant preparation, which contains Fusariumnirenbergiae DBHCYZ-G2-1, its fermentation liquid, its mycelium or the ethyl acetate extract of its fermentation liquid and mycelium as active ingredients.
[0021] Preferably, the antibacterial drug is a drug against Gram-positive bacteria such as Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus and Escherichia coli.
[0022] Preferably, the antioxidant drug is a drug that efficiently scavenges DPPH free radicals.
[0023] The method for preparing the extract of Fusarium fungus F. nirenbergiae DBHCYZ-G2-1 of the present invention has the following advantages:
[0024] (1) The research object of the present invention is fungal extracts, which are highly reproducible;
[0025] (2) The extraction rate is high, there is less solvent residue, and fermentation production can be carried out on different scales.
[0026] The extract of the Fusarium fungus F. nirenbergiae DBHCYZ-G2-1 prepared by the present invention has the following biological activity characteristics:
[0027] (1) The extract of the Fusarium fungus F. nirenbergiae DBHCYZ-G2-1 prepared by the present invention has a significant inhibitory effect on S. aureus at 0.125 mg / mL, and has a significant bactericidal effect on MRSA and E. coli at 0.25 mg / mL.
[0028] (2) The extract of the Fusarium fungus F. nirenbergiae DBHCYZ-G2-1 prepared by the present invention has a DPPH free radical scavenging rate of 50.63% at a concentration of 0.1 mg / mL, showing a moderate antioxidant activity.
[0029] (3) The extract of the Fusarium fungus F. nirenbergiae DBHCYZ-G2-1 prepared by the present invention has a very significant antibacterial rate at a concentration of 20 times the MIC value, and can completely kill the SA colonies infected with coconut milk within 24 hours.
[0030] The advantage of the present invention is that the endophytic fungi of the African spiral flag plant of the Zingiberaceae family were studied for the first time, and a Fusarium fungus Fusarium nirenbergiae DBHCYZ-G2-1 was obtained from it. And the biological activity evaluation and development and application research of its liquid extract were carried out for the first time. It was found for the first time that the liquid extract of this fungus has significant antibacterial and antioxidant activities and no obvious cytotoxicity. This discovery suggests that the Fusarium fungus Fusarium nirenbergiae DBHCYZ-G2-1 provides a new fungal source for the research and development of new non-toxic antibacterial and antioxidant drugs. At the same time, the extract of the strain can be used to prepare natural preservatives, which provides a scientific basis for the development and utilization of natural new antibacterial and antioxidant drugs and food preservatives derived from plant endophytic fungi. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 It is the morphology of the African spiral flag plant and the endophytic fungus F. nirenbergiae DBHCYZ-G2-1;
[0032] Figure 2 It is the antibacterial effect of DBHCYZ-G2-1 extract against S. aureus, MRSA and E. coil;
[0033] Figure 3 are the MIC values of DBHCYZ-G2-1 extract against S. aureus, MRSA, and E. coil;
[0034] Figure 4 The antiseptic and antibacterial results of DBHCYZ-G2-1 extract on coconut water infected with S. aureus; DETAILED DESCRIPTION
[0035] The following examples are provided to further illustrate the present invention, rather than to limit the present invention.
[0036] Example 1
[0037] 1. Isolation, purification and identification of the endophytic fungus Fusarium nirenbergiae DBHCYZ-G2-1 from African spiral flag
[0038] The African spiral flag plant of the present invention was collected from the Jiang Garden of the South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, Guangdong Province on December 22, 2023. The healthy leaves of the African spiral flag were cleaned and programmed surface disinfected by the endophytic fungus isolation method. Take a blank culture dish and pour 75% alcohol × 1, sterile water × 3, 3% sodium hypochlorite × 1, and sterile water × 3 respectively. Put the sample into the alcohol dish for 1 minute, rinse it with water three times, and soak it in the sodium hypochlorite dish for about 30 seconds, and rinse it with water three times. Take the culture dish, cut the tissue into pieces, and plant it on a (PDA) potato dextrose agar medium (add a mixture of penicillin and streptomycin to prevent bacterial growth, the effective concentration is penicillin 100U / mL, streptomycin 0.1mg / mL) plate, and culture it in a 28°C incubator. Regularly observe the endophytic fungal colonies growing from the tissue incision, pick them out in time, and purify them 2-3 times to obtain a single colony of endophytic fungi. Take plant samples and wash them with sterile water and 75% alcohol, and take samples from different locations. Put three samples in each culture medium, seal the culture medium, mark the date and number, and then put it into a constant temperature box for cultivation. After constant temperature cultivation for 1-2 days, observe the colonies and their morphology, and use a new culture dish for screening ( Figure 1 ).
[0039] 2. Identification of the endophytic fungus Fusarium nirenbergiae DBHCYZ-G2-1 in African spiral flag
[0040] At room temperature, the fungal sample was scraped off the culture medium with an inoculation loop or a cell scraper, transferred to a mortar, and the total DNA of the strain was extracted according to the operating steps of the fungal DNA extraction kit (Magen). Afterwards, PCR amplification was performed using the total DNA as a template, and the amplification results were detected by agarose gel electrophoresis for the target band, and sent for sequencing. Subsequently, the above sequencing strains were preliminarily identified by BLAST comparison in the NCBI database. Finally, based on the results of molecular biological identification and combined with the morphological characteristics of the strain, it was determined that the strain was Fusarium nirenbergiae DBHCYZ-G2-1, a Fusarium fungus, with a GenBank number of PQ060430, and the strain was stored in Room 324, Laboratory Building No. 2, Scientific Research Area, South China Botanical Garden, Chinese Academy of Sciences. The applicant guarantees that it will be provided to the public within 20 years from the date of application.
[0041] The base sequence of this strain is:
[0042] GTGGGGCTTCGAGCTTCACTCCCACCCCTGTGAACATACCACTTGTTGCCTCGGCGGA
[0043] TCAGCCCGCTCCCGGTAAAACGGGACGGCCCGCCAGAGGACCCCTAAACTCTGTTTCTA
[0044] TATGTAACTTCTGAGTAAAACCATAAATAAATCAAAACTTTCAACAACGGATCTCTTGGT
[0045] TCTGGCATCGATGAAGAACGCAGCAAAATGCGATAAGTAATGTGAATTGCAGAATTCAG
[0046] TGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGT
[0047] TCGAGCGTCATTTCAACCCTCAAGCACAGCTTGGTGTTGGGACTCGCGTTAATTCGCGTT
[0048] CCCCAAATTGATTGGCGGTCACGTCGAGCTTCCATAGCGTAGTAGTAAAACCCTCGTTAC
[0049] TGGTAATCGTCGCGGCCACGCCGTTAAACCCCAACTTCTGAATGTTGACCTCGGATCAG
[0050] GTAGGAATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA
[0051] Example 2
[0052] 1. Liquid fermentation of the endophytic fungus Fusarium nirenbergiae DBHCYZ-G2-1
[0053] The African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1 preserved in 30% glycerol water was inoculated into potato dextrose agar medium (PDA) and placed in a constant temperature incubator at 28°C for 3 to 4 days to activate the strain. The activated mycelium was then inoculated into 150L potato dextrose liquid culture medium (each liter of culture medium was prepared by the following method: 200g of potatoes were boiled in 300mL of pure water for 20min, the potato juice was filtered, 20g of glucose, 3g of KH2PO4, 1.5g of MgSO4, 10mg of vitamin B1 were added, water was added to make up to 1000mL, and sterilized), and cultured at 28°C and 120r / min for 7 days to obtain a liquid fermentation culture of DBHCYZ-G2-1.
[0054] 2. Preparation of liquid fermentation extract of endophytic fungus Fusarium nirenbergiae DBHCYZ-G2-1
[0055] The liquid fermentation culture of the African spiral flag endophytic fungus F.nirenbergiae DBHCYZ-G2-1 was filtered through three layers of gauze to obtain a bacterial solution and mycelium, respectively. The bacterial solution was added to three times the volume of ethyl acetate, mixed and poured into a separatory funnel, allowed to stand until obvious stratification, the piston of the separatory funnel was opened, the ethyl acetate layer was collected, and a mycelium extract was obtained; at the same time, the mycelium was subjected to organic solvent ultrasonic extraction for 30 minutes using a material ratio of mycelium: ethyl acetate of 1g:30mL, and the bacterial solution extract was obtained by filtering, and the above extraction steps were repeated 3 times, the bacterial solution extract and the mycelium extract were combined, and vacuum decompression and concentration (temperature not exceeding 60°C) were performed to obtain an extract of DBHCYZ-G2-1 liquid fermentation.
[0056] Example 3: Evaluation of antibacterial activity of extracts from the African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1
[0057] In this example, gram-positive bacteria such as Staphylococcus aureus (SA), Methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli (EC) were used as research objects, and the minimum inhibitory concentration (MIC) value was observed and determined using the micro-gradient dilution method and the resazurin colorimetric method. The resazurin colorimetric agent can be reduced from blue to pink in the cytoplasm, and the reduction of the colorimetric agent can intuitively reflect the increase in the number of bacteria. Therefore, the minimum inhibitory concentration (MIC) of the active sample can be determined based on the observed color change of each well solution.
[0058] In the experiment, the three test strains were first activated (the strains preserved in 20% glycerol were inoculated into MHB medium at 37°C and cultured at constant temperature for 12 hours). Then, the extract of DBHCYZ-G2-1 liquid fermentation was diluted to OD = 0.07, that is, the bacterial solution concentration was 1×10 8 CFU / mL. Mix 7.5 mL of indicator solution (100 μg / mL resazurin aqueous solution) with 5 mL of the test bacteria solution (10 8CFU / mL) and add 180μL of the above suspension to the first row of the 96-well plate, and add 100μL to each row from 2 to 8. Subsequently, 20μL of crude extract working solution (1mg / mL), positive control, and negative control are added to the first row of the 96-well plate in sequence. After mixing the test sample with 180μL of the suspension, take out 100μL of it and move it to the second row to mix evenly, then take 100μL of the second row and move it to the third row to mix evenly, and dilute the third to eighth rows in this way by double gradient dilution. Finally, place the 96-well plate in a 37℃ constant temperature incubator for 6 to 12h, observe the color change of resazurin, and determine the MIC value of the test sample. The bacterial solution turns red for no antibacterial activity, blue for antibacterial activity, and the lowest dilution concentration at which the bacterial solution maintains blue is considered to be the minimum inhibitory concentration of the compound to be tested. Two parallel samples are made for each sample, and vancomycin is used as a positive control drug.
[0059] The results show that the extract of DBHCYZ-G2-1 liquid fermentation in Example 2 has obvious antibacterial activity against Gram-positive bacteria, and has a significant inhibitory effect on S. aureus at 0.125 mg / mL. In addition, the extract of DBHCYZ-G2-1 liquid fermentation has obvious bactericidal effects on Methicillin-resistant S. aureus and E. coli at 0.25 mg / mL. The above results show that the F. nirenbergiae DBHCYZ-G2-1 extract has good application prospects in antibacterial and antiseptic properties. The specific experimental results are as follows Figure 2 , 3 And as shown in Table 1.
[0060] Table 1. MIC values of DBHCYZ-G2-1 extract against S. aureus, MRSA and E. coil
[0061]
[0062] Example 4: Antimicrobial activity test of extract from African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1
[0063] In this implementation, the DPPH free radical scavenging method was used to test the in vitro antioxidant activity of the DBHCYZ-G2-1 extract. The main basis was to evaluate the antioxidant activity of the tested samples based on the color change of the DPPH free radical solution.
[0064] First, use anhydrous ethanol as solvent to prepare DPPH into a 0.1mmol / L solution and store it in the dark. Use DMSO as solvent to dilute the positive control vitamin C into 500, 250, 125, 62.5, 31.25, 15.625μM working solutions, and the extract of DBHCYZ-G2-1 liquid fermentation is prepared into a 1000μg / mL working solution. Then add 4 wells of crude extract samples, 4 wells of each concentration of positive drugs, and 8 wells of negative control DMSO to a 96-well plate, 10μL / well. Add 90μLDPH solution to 3 of the duplicate sample wells and 90μL methanol solution to the other well. After standing in the dark at room temperature for 30 minutes, measure the absorbance of sample A at 517nm. Measure the absorbance value at 517nm with an enzyme reader and calculate the inhibition rate.
[0065] Calculation formula: Inhibition (%) = [1-(OD 样品 -OD 样品对照 ) / (OD 阴性对照 -OD 空白对照 )]×100.
[0066] The results of the antioxidant activity test showed that the DPPH radical scavenging rate of the liquid fermentation extract of the African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1 in Example 1 was 50.63%, showing moderate antioxidant activity (Table 2), indicating that the liquid fermentation extract of F. nirenbergiae DBHCYZ-G2-1 not only has application value in preservation, but also provides a new endophytic fungal resource for the discovery of antioxidant lead compounds.
[0067] Table 2. Evaluation results of antioxidant activity of crude extracts
[0068]
[0069] Example 4: Antimicrobial activity test of extract from African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1
[0070] The cytotoxicity of the extracts from the liquid fermentation of the endophytic fungus F. nirenbergiae DBHCYZ-G2-1 was tested by MTT assay.
[0071] 1. Test reagents: The extract of the liquid fermentation of the African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1 prepared by the present invention was dissolved in dimethyl sulfoxide (DMSO) to obtain a mother solution with a concentration of 100 mg / mL, and then diluted with PBS to a desired concentration. The positive control was doxorubicin.
[0072] The tumor cell lines used in this experiment are human non-small cell lung cancer cells (A549) and human cervical cancer cells (Hela).
[0073] 2. Experimental method: Human non-small cell lung cancer cells (A549) and human cervical cancer cells (Hela) in the logarithmic growth phase were digested with trypsin, stained with trypan blue and counted. After the cell viability was greater than 95% by trypan blue exclusion test, the cell concentration was adjusted to 1×10 with fresh DMEM medium. 4 / mL, pick appropriate cells and inoculate them in a 96-well plate, add 90μL of cell suspension to each well, set up 3 blank wells as control and zero, and culture in a 37℃, 5% CO2 incubator for 24h. After the cells adhere to the wall, add 10μL of 1mg / mL DMSO solution of liquid fermentation extract of African spiral flag endophytic fungus F.nirenbergiae DBHCYZ-G2-1 to each well, add 10μL DMSO / DMEM diluent to the negative control (DMSO concentration is lower than 0.5% after entering the well), use doxorubicin as the positive control, and set three replicates. After culturing in a 37℃, 5% CO2 incubator for 72h, add 10μL of MTT solution (5mg / mL) to each well and incubate in a 37℃ incubator for 4h. Abandon the cell culture medium, add 100μL of DMSO solution to each well, measure the absorbance at 490nm, and calculate the inhibition rate based on the absorbance.
[0074] Calculation formula: Inhibition (%) = [1-(A 样品 -A 空白 ) / (A 对照 -A 空白 )]×100
[0075] The results of the cytotoxicity test showed that the liquid fermentation extract of the African spiral flag endophytic fungus F.nirenbergiaeDBHCYZ-G2-1 of Example 1 had an inhibition rate of 17.99% and 29.65% on non-small cell lung cancer cells (A549) and human cervical cancer cells (Hela) (Table 3), respectively, which was very different from the positive drug doxorubicin. The above results showed that the extract of the African spiral flag endophytic fungus F.nirenbergiae DBHCYZ-G2-1 had no obvious cytotoxicity. It was suggested that the liquid fermentation extract of F.nirenbergiaeDBHCYZ-G2-1 had a certain safety guarantee for application and development as an antibacterial and antiseptic product.
[0076] Table 3. Cytotoxicity evaluation results of DBHCYZ-G2-1 extract
[0077]
[0078] Example 5: Antiseptic and antibacterial test of the extract of the African spiral flag endophytic fungus F. nirenbergiae DBHCYZ-G2-1 on coconut water
[0079] In this implementation, the plate colony counting method was used to evaluate the antibacterial and preservative efficacy of the extract of F. nirenbergiae DBHCYZ-G2-1 liquid fermentation on coconut water. The antibacterial effect was mainly measured by the difference in the number of colonies on the plate after the intervention of the extract of F. nirenbergiae DBHCYZ-G2-1 liquid fermentation and the blank group as the number of culture days changed.
[0080] Add 30 μL of the activated S. aureus solution to a 50 mL centrifuge tube and shake overnight at 200 rpm and 37°C. Dilute the S. aureus to 1×10 6 CFU / mL, and then diluted 1000 times, 1mL of bacterial solution was co-cultured with crude extract. The negative control did not contain antimicrobial agents, the crude extract concentration was 20×MIC, and it was stored at 4°C; the colony counting method was used to determine the microbial concentration on days 1, 2, 3, and 4. Take 1mL of bacterial solution in an EP tube, centrifuge at 3500rpm for 6min. After centrifugation, discard the supernatant, resuspend with sterile coconut water, and adjust the bacterial solution concentration to OD 600 = about 0.07. Dilute the adjusted bacterial solution 1000 times. Take 1mL of the diluted bacterial solution in an EP tube, add F. nirenbergiae extract (20×MIC concentration), and store in a 4°C refrigerator. Then, take 100μL of the bacterial solution on the first, second, and third day, spread it on the BHA plate, incubate it inverted at 37°C for 24 hours, and use the colony counting method to determine the microbial concentration on the 1st, 2nd, 3rd, and 4th day.
[0081] The results of the antiseptic and antibacterial experiment on coconut water with the liquid fermentation extract of F.nirenbergiae DBHCYZ-G2-1 showed that the liquid fermentation extract of the African spiral flag endophytic fungus F.nirenbergiae DBHCYZ-G2-1 in Example 1 had very significant bactericidal and antiseptic activity. Under the intervention condition of 20 times the MIC value concentration, compared with the blank group, with the extension of culture time, the number of S.aureus bacteria in the 20 times MIC value F.nirenbergiae DBHCYZ-G2-1 extract intervention group was significantly reduced, and the antibacterial rate of F.nirenbergiae extract was extremely significant, and the colony could be completely killed within 24 hours of intervention. The above results show that the liquid fermentation extract of the African spiral flag endophytic fungus F.nirenbergiae DBHCYZ-G2-1 has important application prospects in the application and development of bactericidal and antiseptic products. The specific experimental results are as follows Figure 4 shown.
[0082] The above are only preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as limiting the present invention, and the protection scope of the present invention should be based on the scope defined by the claims. For ordinary technicians in this technical field, many improvements and modifications can be made without departing from the spirit and scope of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims
1. Use of Fusarium nirenbergiae DBHCYZ-G2-1, its fermentation broth, its mycelium or organic solvent extracts of its fermentation broth and mycelium in the preparation of antibacterial, antitumor drugs or antioxidant preparations.
2. The use according to claim 1, characterized in that: The antibacterial drug is a drug against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Escherichia coli; the anti-tumor drug is an anti-lung cancer or cervical cancer drug; and the antioxidant preparation is an antioxidant drug or an antioxidant cosmetic.
3. The use according to claim 1, characterized in that: The antibacterial property is an antiseptic, preferably an antiseptic for coconut water.
4. The use according to claim 1, characterized in that: The fermentation broth and mycelium are obtained by inoculating Fusariumnirenbergiae DBHCYZ-G2-1 into a culture medium in which the strain can grow, and the fermentation broth and mycelium are obtained by separation; preferably, the culture medium is PDB culture medium, and the preparation method of the PDB culture medium per liter is: boil 200g of potatoes with 300mL of pure water, boil for 20min, filter to obtain potato juice, add 20g of glucose, 3g of KH2PO4, 1.5g of MgSO4, 10mg of vitamin B1, add water to make up to 1000mL, and sterilize to obtain the obtained product.
5. The use according to claim 4, characterized in that: The culture medium is cultured at 28°C and 120 r / min, preferably for 7 days.
6. The use according to claim 1, characterized in that: The organic solvent is ethyl acetate.
7. The use according to claim 6, characterized in that: The organic solvent extract is prepared by adding the fermentation liquid into ethyl acetate, mixing the mixture and pouring the mixture into a separatory funnel for extraction, standing the mixture until distinct stratification occurs, opening the piston of the separatory funnel, collecting the ethyl acetate layer of the fermentation liquid, and obtaining a bacterial liquid extract; at the same time, ultrasonic extraction of mycelium using ethyl acetate is performed, and mycelium extract is obtained by filtering the mycelium extract, combining the bacterial liquid extract and the mycelium extract, and performing vacuum decompression concentration to obtain an ethyl acetate extract.
8. The use according to claim 7, characterized in that: The extraction temperature is 25-30° C., and the extraction is preferably performed 3-5 times.
9. The use according to claim 7, characterized in that: The vacuum concentration is carried out at a temperature of 50-60°C.
10. An antibacterial, antitumor drug or antioxidant preparation comprising Fusarium nirenbergiae DBHCYZ-G2-1, its fermentation broth, its mycelium or an ethyl acetate extract of its fermentation broth and mycelium as an active ingredient.
Citation Information
Patent Citations
Pigeonpea endophytic fungi strain with high yield of cajaninstilbene acid and its application
CN102732428A
Peony endophytic fungus and application thereof
CN105039176A
Ginkgo biloba endophytic fungus and application thereof in antibiosis and anti-tumor
CN116419976A
Endophytic fungus in ginkgo biloba and Anti-bacterial and antitumor application thereof
WO2022188162A1
